Indrayani Biotech Board of Directors
Get the latest insights into the leadership at Indrayani Biotech. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Nangavaram Mahadevan Ranganathan | Chairman |
| Mr. Kasiraman Sayee Sundar | Managing Director |
| Mr. Singarababu Indirakumar | Director |
| Mr. G Swaminathan | Director |
| Mr. Muthukrishnan Ramesh | Director |
| Mr. Kannimangalam Subramanyan Vaidyanathan | Director |
| Mrs. Lakshmiprabha Kasiraman | Director |
| Dr. Bokara Nagarajan Padmaja Priyadarshini | Director |
Indrayani Biotech Share price
INDRANIB
12.86
0.23 (1.82%)Last updated on 24 Sep, 2025 | 15:26 IST
BUYSELL
Today's High
13.49
Today's Low
12.30
52 Week Low
10.20
52 Week High
48.90
The current prices are delayed, login to your account for live prices
LoginIndrayani Biotech FAQs
The board at Indrayani Biotech consists of experienced professionals, including Mr. Nangavaram Mahadevan Ranganathan , Mr. Kasiraman Sayee Sundar , and others, overseeing the company’s strategic and corporate governance.
Directors at Indrayani Biotech are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Nangavaram Mahadevan Ranganathan is the current chairman at Indrayani Biotech.
Executive directors at Indrayani Biotech are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Indrayani Biotech adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Indrayani Biotech, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.